Current
22.5×
5-Year Average
47.8×
All-Time High
651.8×
All-Time Low
9.7×
P/E Ratio daily chart for Zimmer Biomet Holdings (ZBH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Zimmer Biomet Holdings (ZBH) from 2001 to 2025
| 2025 | $17.73B | $705.20M | 25.1× | +1.9× | |
| 2024 | $21.03B | $903.80M | 23.3× | -1.4× | |
| 2023 | $25.30B | $1.02B | 24.7× | -90.9× | |
| 2022 | $26.75B | $231.40M | 115.6× | +51.5× | |
| 2021 | $25.74B | $401.60M | 64.1× | — | |
| 2020 | $31.00B | −$138.90M | — | — | |
| 2019 | $29.88B | $1.13B | 26.4× | — | |
| 2018 | $20.57B | −$379.20M | — | — | |
| 2017 | $23.70B | $1.81B | 13.1× | -52.5× | |
| 2016 | $20.06B | $305.90M | 65.6× | -69.9× | |
| 2015 | $19.91B | $147.00M | 135.5× | +109.8× | |
| 2014 | $18.71B | $727.70M | 25.7× | +5.4× | |
| 2013 | $15.43B | $761.00M | 20.3× | +5.8× | |
| 2012 | $10.91B | $755.00M | 14.5× | +2.4× | |
| 2011 | $9.19B | $760.80M | 12.1× | -4.7× | |
| 2010 | $10.03B | $596.90M | 16.8× | +0.6× | |
| 2009 | $11.64B | $717.40M | 16.2× | +6.0× | |
| 2008 | $8.69B | $848.60M | 10.2× | -9.1× | |
| 2007 | $14.92B | $773.20M | 19.3× | -2.3× | |
| 2006 | $18.01B | $834.50M | 21.6× | -0.5× | |
| 2005 | $16.21B | $732.50M | 22.1× | -13.2× | |
| 2004 | $19.13B | $541.80M | 35.3× | -12.6× | |
| 2003 | $16.59B | $346.30M | 47.9× | +17.3× | |
| 2002 | $7.88B | $257.80M | 30.6× | -7.8× | |
| 2001 | $5.75B | $149.80M | 38.4× | — |
- 202525.1×
- 202423.3×
- 202324.7×
- 2022115.6×
- 202164.1×
- 2020—
- 201926.4×
- 2018—
- 201713.1×
- 201665.6×
- 2015135.5×
- 201425.7×
- 201320.3×
- 201214.5×
- 201112.1×
- 201016.8×
- 200916.2×
- 200810.2×
- 200719.3×
- 200621.6×
- 200522.1×
- 200435.3×
- 200347.9×
- 200230.6×
- 200138.4×
About P/E Ratio at Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings (ZBH) P/E ratio is 22.5× as of June 5, 2026. The 5-year average is 47.8×. The sector median currently stands at 25.0×. The current ratio is at the 21th percentile of its own 10-year history.
Zimmer Biomet Holdings (ZBH) historical P/E ratio has ranged from a low of 9.7× (2009) to a high of 651.8× (2020) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Zimmer Biomet Holdings P/E Ratio by Year
Zimmer Biomet Holdings P/E Ratio 2025: 25.1×
Zimmer Biomet Holdings (ZBH) P/E ratio in 2025 was 25.1×, expanded from 23.3× the prior year.
Zimmer Biomet Holdings P/E Ratio 2024: 23.3×
Zimmer Biomet Holdings (ZBH) P/E ratio in 2024 was 23.3×, contracted from 24.7× the prior year.
Zimmer Biomet Holdings P/E Ratio 2023: 24.7×
Zimmer Biomet Holdings (ZBH) P/E ratio in 2023 was 24.7×, contracted from 115.6× the prior year.
Zimmer Biomet Holdings P/E Ratio 2022: 115.6×
Zimmer Biomet Holdings (ZBH) P/E ratio in 2022 was 115.6×, expanded from 64.1× the prior year.
Zimmer Biomet Holdings P/E Ratio 2021: 64.1×
Zimmer Biomet Holdings (ZBH) P/E ratio in 2021 was 64.1×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Zimmer Biomet Holdings (ZBH), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Zimmer Biomet Holdings (ZBH) Key Financials
Charts, filings, and peer comparison for every metric